Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
CIMAvax Vaccine + Nivolumab + Pembrolizumab for Non-small Cell Lung Cancer and Squamous Head and Neck Cancer
Recruiting1 awardPhase 1 & 2
Roslyn, New York
This trial is testing a combination of two cancer treatments - a vaccine and an immunotherapy drug - to see if they are more effective than either treatment alone in treating patients with non-small cell lung cancer or squamous head and neck cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.